Quinn Opportunity Partners LLC Prothena Corp Public LTD CO Transaction History
Quinn Opportunity Partners LLC
- $1.08 Billion
- Q2 2025
A detailed history of Quinn Opportunity Partners LLC transactions in Prothena Corp Public LTD CO stock. As of the latest transaction made, Quinn Opportunity Partners LLC holds 50,000 shares of PRTA stock, worth $384,500. This represents 0.03% of its overall portfolio holdings.
Number of Shares
50,000Holding current value
$384,500% of portfolio
0.03%Shares
1 transactions
Others Institutions Holding PRTA
# of Institutions
192Shares Held
44.9MCall Options Held
251KPut Options Held
79.2K-
Eco R1 Capital, LLC San Francisco, CA11.6MShares$89.1 Million11.27% of portfolio
-
Wellington Management Group LLP Boston, MA5.2MShares$40 Million0.01% of portfolio
-
Black Rock Inc. New York, NY3.86MShares$29.7 Million0.0% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD3.46MShares$26.6 Million0.01% of portfolio
-
Armistice Capital, LLC New York, NY2.2MShares$16.9 Million0.41% of portfolio
About PROTHENA CORP PUBLIC LTD CO
- Ticker PRTA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 46,922,800
- Market Cap $361M
- Description
- Prothena Corporation plc, a late-stage clinical company, focuses on discovery and development of novel therapies for life-threatening diseases in the United States. The company is involved in developing Birtamimab, an investigational humanized antibody that is in Phase III clinical trial for the treatment of AL amyloidosis; Prasinezumab, a human...